N-Acetyl Cysteine Plus Naltrexone in Methamphetamine Dependence
Phase 2
Completed
- Conditions
- Methamphetamine Dependence
- Interventions
- Drug: Placebo
- First Posted Date
- 2006-06-01
- Last Posted Date
- 2022-08-23
- Lead Sponsor
- University of Chicago
- Target Recruit Count
- 45
- Registration Number
- NCT00332605
- Locations
- 🇺🇸
University of Chicago, Chicago, Illinois, United States
Early Directed Physical Therapy in the Management of Mechanically Ventilated Patients in a Medical Intensive Care Unit
Phase 2
Completed
- Conditions
- Mechanically Ventilated Patients
- Interventions
- Procedure: early PT OT
- First Posted Date
- 2006-05-04
- Last Posted Date
- 2014-03-18
- Lead Sponsor
- University of Chicago
- Target Recruit Count
- 104
- Registration Number
- NCT00322010
- Locations
- 🇺🇸
University of Chicago, Chicago, Illinois, United States
Comparison of Sirolimus and Azathioprine in Lung Transplantation
Phase 4
Completed
- Conditions
- Delayed Graft FunctionAcute Graft Rejection
- Interventions
- First Posted Date
- 2006-05-04
- Last Posted Date
- 2016-09-21
- Lead Sponsor
- University of Chicago
- Target Recruit Count
- 181
- Registration Number
- NCT00321906
- Locations
- 🇺🇸
University of Chicago, Chicago, Illinois, United States
Trial of Adalimumab in Progressive Sarcoidosis
- First Posted Date
- 2006-04-05
- Last Posted Date
- 2020-08-25
- Lead Sponsor
- University of Chicago
- Target Recruit Count
- 11
- Registration Number
- NCT00311246
- Locations
- 🇺🇸
The University of Chicago, Chicago, Illinois, United States
Measurement of Jugular Venous Pulse in Critically Ill Patients.
Terminated
- Conditions
- Jugular Venous Pulse Measurement in Critically Ill Patients
- First Posted Date
- 2006-03-16
- Last Posted Date
- 2013-09-05
- Lead Sponsor
- University of Chicago
- Target Recruit Count
- 36
- Registration Number
- NCT00303355
- Locations
- 🇺🇸
University of Chicago, Chicago, Illinois, United States
Efficacy of Naltrexone in Women's Smoking Cessation
Phase 2
Completed
- Conditions
- SmokingSmoking Cessation
- Interventions
- Drug: Placebo (for Naltrexone)
- First Posted Date
- 2005-12-29
- Last Posted Date
- 2023-03-23
- Lead Sponsor
- University of Chicago
- Target Recruit Count
- 333
- Registration Number
- NCT00271024
- Locations
- 🇺🇸
The University of Chicago, Department of Psychiatry, Chicago, Illinois, United States
The Significance of Glucose Intolerance in the Pathogenesis of Idiopathic Axonal Polyneuropathy
Phase 1
Terminated
- Conditions
- Idiopathic Axonal PolyneuropathyAbnormal OGTT
- First Posted Date
- 2005-09-28
- Last Posted Date
- 2013-09-05
- Lead Sponsor
- University of Chicago
- Target Recruit Count
- 40
- Registration Number
- NCT00228345
- Locations
- 🇺🇸
University of Chicago, Chicago, Illinois, United States
Assessing CPR Quality During In-Hospital Cardiac Arrest
Phase 2
Terminated
- Conditions
- Cardiac Arrest
- First Posted Date
- 2005-09-28
- Last Posted Date
- 2013-09-23
- Lead Sponsor
- University of Chicago
- Target Recruit Count
- 200
- Registration Number
- NCT00228293
- Locations
- 🇺🇸
University of Chicago Hospitals, Chicago, Illinois, United States
A Study of Chemoradiotherapy for Intermediate Stage/Selected Stage IV Cancers of the Head and Neck
Phase 2
Completed
- Conditions
- Head and Neck Cancer
- Interventions
- Drug: 5-Fluorouracil, Hydroxyurea-[FHX]
- First Posted Date
- 2005-09-20
- Last Posted Date
- 2014-01-17
- Lead Sponsor
- University of Chicago
- Target Recruit Count
- 23
- Registration Number
- NCT00203905
- Locations
- 🇺🇸
The University of Chicago, Chicago, Illinois, United States
Trial Comparing Cetuximab With Pemetrexed/Cetuximab Therapy for Non-Small Cell Lung Cancer
- First Posted Date
- 2005-09-20
- Last Posted Date
- 2014-03-31
- Lead Sponsor
- University of Chicago
- Target Recruit Count
- 55
- Registration Number
- NCT00203931
- Locations
- 🇺🇸
The University of Chicago, Chicago, Illinois, United States
© Copyright 2025. All Rights Reserved by MedPath